review article | Q7318358 |
scholarly article | Q13442814 |
P2093 | author name string | Jian Shi | |
P2860 | cites work | Overexpression of miR-128 specifically inhibits the truncated isoform of NTRK3 and upregulates BCL2 in SH-SY5Y neuroblastoma cells | Q21263029 |
Curcumin-loaded nanoparticles potently induce adult neurogenesis and reverse cognitive deficits in Alzheimer's disease model via canonical Wnt/β-catenin pathway | Q46812187 | ||
p75 neurotrophin receptor expression defines a population of BDNF-responsive neurogenic precursor cells | Q48171858 | ||
MicroRNA loss enhances learning and memory in mice | Q48174132 | ||
Prevention of Lymphocyte Neurotoxic Effects by microRNA Delivery. | Q48633308 | ||
Neutralization of nerve growth factor impairs proliferation and differentiation of adult neural progenitors in the subventricular zone | Q48787473 | ||
The Aicardi–Goutières syndrome. Molecular and clinical features of RNAse deficiency and microRNA overload | Q57898974 | ||
Pathogenic LRRK2 negatively regulates microRNA-mediated translational repression | Q24293587 | ||
TUT4 in concert with Lin28 suppresses microRNA biogenesis through pre-microRNA uridylation | Q24308810 | ||
Phosphorylation of the human microRNA-generating complex mediates MAPK/Erk signaling | Q24321740 | ||
A cAMP-response element binding protein-induced microRNA regulates neuronal morphogenesis | Q24537628 | ||
Secretory mechanisms and intercellular transfer of microRNAs in living cells | Q24603413 | ||
A minicircuitry involving REST and CREB controls miR-9-2 expression during human neuronal differentiation | Q24608565 | ||
A novel pathway regulates memory and plasticity via SIRT1 and miR-134 | Q24624906 | ||
microRNA-132 regulates dendritic growth and arborization of newborn neurons in the adult hippocampus | Q24631418 | ||
Proliferating cells express mRNAs with shortened 3' untranslated regions and fewer microRNA target sites | Q24653978 | ||
Neurotrophin-regulated signalling pathways | Q24678332 | ||
The functions of animal microRNAs | Q27860621 | ||
Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? | Q27860893 | ||
MicroRNAs: genomics, biogenesis, mechanism, and function | Q27861070 | ||
Selectivity in neurotrophin signaling: theme and variations | Q28211196 | ||
Homeostatic regulation of MeCP2 expression by a CREB-induced microRNA | Q28256854 | ||
The bifunctional microRNA miR-9/miR-9* regulates REST and CoREST and is downregulated in Huntington's disease | Q28305485 | ||
MicroRNA-221 modulates RSV replication in human bronchial epithelium by targeting NGF expression | Q28395684 | ||
Experimental verification of a predicted intronic microRNA in human NGFR gene with a potential pro-apoptotic function | Q28482787 | ||
A small molecule p75(NTR) ligand protects neurogenesis after traumatic brain injury | Q28568991 | ||
MeCP2-dependent repression of an imprinted miR-184 released by depolarization | Q28586909 | ||
Modification of Mecp2 dosage alters axonal transport through the Huntingtin/Hap1 pathway | Q28941208 | ||
Treatment of HCV infection by targeting microRNA | Q29547712 | ||
Spherical nucleic acid nanoparticle conjugates as an RNAi-based therapy for glioblastoma | Q30577878 | ||
Protective effects of octacosanol on 6-hydroxydopamine-induced Parkinsonism in rats via regulation of ProNGF and NGF signaling | Q33557497 | ||
Dual regulation of miRNA biogenesis generates target specificity in neurotrophin-induced protein synthesis | Q33819129 | ||
Set9, NF-κB, and microRNA-21 mediate berberine-induced apoptosis of human multiple myeloma cells | Q33862343 | ||
Formulation and optimization of polymeric nanoparticles for intranasal delivery of lorazepam using Box-Behnken design: in vitro and in vivo evaluation | Q34003837 | ||
Regulation of miR-146a by RelA/NFkB and p53 in STHdh(Q111)/Hdh(Q111) cells, a cell model of Huntington's disease | Q34009621 | ||
Regulation of the miR-212/132 locus by MSK1 and CREB in response to neurotrophins | Q34105857 | ||
Ischemic preconditioning regulates expression of microRNAs and a predicted target, MeCP2, in mouse cortex | Q34112461 | ||
Neuroblastoma: biological insights into a clinical enigma | Q34180699 | ||
MicroRNA expression profiling of NGF-treated PC12 cells revealed a critical role for miR-221 in neuronal differentiation | Q34265015 | ||
Small-molecule modulation of neurotrophin receptors: a strategy for the treatment of neurological disease | Q34366768 | ||
Clinical relevance of the neurotrophins and their receptors | Q34484451 | ||
miR-200c targets a NF-κB up-regulated TrkB/NTF3 autocrine signaling loop to enhance anoikis sensitivity in triple negative breast cancer | Q34490836 | ||
Genomic loss of tumor suppressor miRNA-204 promotes cancer cell migration and invasion by activating AKT/mTOR/Rac1 signaling and actin reorganization | Q34533814 | ||
Alterations of serum levels of BDNF-related miRNAs in patients with depression | Q34737583 | ||
A biological function for the neuronal activity-dependent component of Bdnf transcription in the development of cortical inhibition | Q34889693 | ||
MiR-34, SIRT1 and p53: the feedback loop | Q34946471 | ||
Sustained activation of ERK1/2 by NGF induces microRNA-221 and 222 in PC12 cells | Q34980725 | ||
Biocompatibility and biodistribution of suberoylanilide hydroxamic acid loaded poly (DL-lactide-co-glycolide) nanoparticles for targeted drug delivery in cancer | Q35222227 | ||
The interplay between microRNAs and the neurotrophin receptor tropomyosin-related kinase C controls proliferation of human neuroblastoma cells. | Q35808837 | ||
What turns CREB on? | Q35874745 | ||
NF-кB-regulated micro RNAs (miRNAs) in primary human brain cells | Q35874830 | ||
Neurotrophin signalling in health and disease | Q36367776 | ||
Expression and function of TRK-B and BDNF in human neuroblastomas | Q36644617 | ||
The p75 neurotrophin receptor | Q36903408 | ||
Brain-derived neurotrophic factor signaling does not stimulate subventricular zone neurogenesis in adult mice and rats | Q37137771 | ||
A set of differentially expressed miRNAs, including miR-30a-5p, act as post-transcriptional inhibitors of BDNF in prefrontal cortex | Q37294746 | ||
MicroRNA history: discovery, recent applications, and next frontiers. | Q37860516 | ||
MicroRNA function and neurotrophin BDNF. | Q37896943 | ||
Role of microRNAs in central nervous system development and pathology | Q37933185 | ||
PLGA-based nanoparticles: an overview of biomedical applications. | Q37986980 | ||
Neurotrophin regulation of neural circuit development and function | Q38068714 | ||
A sight on the current nanoparticle-based gene delivery vectors | Q38220813 | ||
Causes and Consequences of MicroRNA Dysregulation in Neurodegenerative Diseases | Q38224066 | ||
Neurotrophin-3 mRNA a putative target of miR21 following status epilepticus | Q38330929 | ||
Synthesis, characterization, and evaluation of poly (D,L-lactide-co-glycolide)-based nanoformulation of miRNA-150: potential implications for pancreatic cancer therapy | Q38980514 | ||
Coencapsulation of tumor lysate and CpG-ODN in PLGA-microspheres enables successful immunotherapy of prostate carcinoma in TRAMP mice | Q39329315 | ||
Brain-derived neurotrophic factor expression is repressed during myogenic differentiation by miR-206. | Q39443445 | ||
MiR-21 is an Ngf-modulated microRNA that supports Ngf signaling and regulates neuronal degeneration in PC12 cells | Q39572951 | ||
Tyrosine kinase B receptor and BDNF expression in ovarian cancers - Effect on cell migration, angiogenesis and clinical outcome | Q39869373 | ||
Mir-592 regulates the induction and cell death-promoting activity of p75NTR in neuronal ischemic injury | Q41869127 | ||
Ligand-independent signaling by disulfide-crosslinked dimers of the p75 neurotrophin receptor | Q42543970 | ||
Comparative sequence analysis reveals an intricate network among REST, CREB and miRNA in mediating neuronal gene expression | Q42822474 | ||
Expression of trkB in human neuroblastoma in relation to MYCN expression and retinoic acid treatment | Q44478935 | ||
BDNF regulates the translation of a select group of mRNAs by a mammalian target of rapamycin-phosphatidylinositol 3-kinase-dependent pathway during neuronal development. | Q45022922 | ||
MicroRNA profiling and the role of microRNA-132 in neurodegeneration using a rat model | Q45169578 | ||
Relationship between BDNF expression in major striatal afferents, striatum morphology and motor behavior in the R6/2 mouse model of Huntington's disease. | Q45290002 | ||
A microRNA-based gene dysregulation pathway in Huntington's disease | Q45307225 | ||
NPY modulates miR-30a-5p and BDNF in opposite direction in an in vitro model of Alzheimer disease: a possible role in neuroprotection? | Q46161319 | ||
P275 | copyright license | Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported | Q19125045 |
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | encephalopathy | Q576349 |
neoplasm | Q1216998 | ||
microRNA | Q310899 | ||
regulation of gene expression | Q411391 | ||
nerve growth factors | Q98072643 | ||
P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
P304 | page(s) | 149-57 | |
P577 | publication date | 2015-02-01 | |
P1433 | published in | Acta Pharmacologica Sinica | Q15749885 |
P1476 | title | Regulatory networks between neurotrophins and miRNAs in brain diseases and cancers | |
P478 | volume | 36 |
Q36503572 | ADAMTS-4 promotes neurodegeneration in a mouse model of amyotrophic lateral sclerosis |
Q89563123 | Altered circulatory levels of miR-128, BDNF, cortisol and shortened telomeres in patients with type 2 diabetes and depression |
Q36088484 | An Encapsulation of Gene Signatures for Hepatocellular Carcinoma, MicroRNA-132 Predicted Target Genes and the Corresponding Overlaps |
Q59791985 | Anabolic Androgenic Steroids: Searching New Molecular Biomarkers |
Q64098657 | Ancestral Stress Alters Lifetime Mental Health Trajectories and Cortical Neuromorphology via Epigenetic Regulation |
Q38623164 | Anti-microRNAs as Novel Therapeutic Agents in the Clinical Management of Alzheimer's Disease |
Q89682822 | BDNF as a Promising Therapeutic Agent in Parkinson's Disease |
Q57285325 | Comparison of two different media for maturation rate of neural progenitor cells to neuronal and glial cells emphasizing on expression of neurotrophins and their respective receptors |
Q26752550 | Considering Exosomal miR-21 as a Biomarker for Cancer |
Q93081557 | Deficiency in Androgen Receptor Aggravates the Depressive-Like Behaviors in Chronic Mild Stress Model of Depression |
Q42365342 | Down-Regulation of miR-146a Expression Induces Allergic Conjunctivitis in Mice by Increasing TSLP Level |
Q37734809 | Down-regulation of miR-146a-5p and its potential targets in hepatocellular carcinoma validated by a TCGA- and GEO-based study |
Q42276827 | Identification of common oncogenic and early developmental pathways in the ovarian carcinomas controlling by distinct prognostically significant microRNA subsets |
Q50123796 | MicroRNAs as biomarkers for human glioblastoma: progress and potential. |
Q40976967 | Nerve growth factor improves visual loss in childhood optic gliomas: a randomized, double-blind, phase II clinical trial |
Q41894465 | Sirtuin1 protects endothelial Caveolin-1 expression and preserves endothelial function via suppressing miR-204 and endoplasmic reticulum stress. |
Q92920850 | The Role of Altered BDNF/TrkB Signaling in Amyotrophic Lateral Sclerosis |
Search more.